Helicobacter pylori eradication therapies in the era of increasing antibiotic resistance: A paradigm shift to improved efficacy

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Georgopoulos, Sotirios D ^a   Papastergiou, Vasilios ^b   Karatapanis, Stylianos ^a,b  

^a ATHENS MEDICAL CENTER   (Greece)

^b General Hospital of Rhodes   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; IMIDAZOLE; LEVOFLOXACIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; RIFABUTIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; DISEASE CONTROL; DRUG EFFICACY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; REVIEW; VALIDATION PROCESS;

EID: 84863664315     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/757926     Document Type: Review

References (112)

1. Moayyedi P., Hunt R. H., Helicobacter pylori public health implications Helicobacter 2004 9 supplement 1 67 72 (Pubitemid 39274109)
2. Suerbaum S., Michetti P., Helicobacter pylori infection The New England Journal of Medicine 2002 347 15 1175 1186
3. Fuccio L., Zagari R. M., Eusebi L. H., Laterza L., Cennamo V., Ceroni L., Grilli D., Bazzoli F., Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Annals of Internal Medicine 2009 151 2 121 128
4. Fukase K., Kato M., Kikuchi S., Inoue K., Uemura N., Okamoto S., Terao S., Amagai K., Hayashi S., Asaka M., Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial The Lancet 2008 372 9636 392 397
5. Malfertheiner P., Chan F. K., McColl K. E., Peptic ulcer disease The Lancet 2009 374 9699 1449 1461
6. Stathis A., Bertoni F., Zucca E., Treatment of gastric marginal zone lymphoma of MALT type Expert Opinion on Pharmacotherapy 2010 11 13 2141 2152
7. Graham D. Y., Antibiotic resistance in Helicobacter pylori: implications for therapy Gastroenterology 1998 115 5 1272 1277 (Pubitemid 28485620)
8. Mégraud F., H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 2004 53 9 1374 1384 (Pubitemid 39120130)
9. Megraud F., Helicobacter pylori and antibiotic resistance Gut 2007 56 11 1502 (Pubitemid 350033185)
10. Broutet N., Tchamgoué S., Pereira E., Lamouliatte H., Salamon R., Mégraud F., Risk factors for failure of Helicobacter pylori therapyresults of an individual data analysis of 2751 patients Alimentary Pharmacology Therapeutics 2003 17 1 99 109 (Pubitemid 36140439)
11. Georgopoulos S. D., Ladas S. D., Karatapanis S., Mentis A., Spiliadi C., Artikis V., Raptis S. A., Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin Digestive Diseases and Sciences 2000 45 1 63 67 (Pubitemid 30111689)
12. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group Gut 1997 41 1 8 13
13. Lind T., van Zanten S. V., Unge P., Spiller R., Bayerdrffer E., O'Morain C., Bardhan K. D., Bradette M., Chiba N., Wrangstadh M., Cederberg C., Idstrm J. P., Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study Helicobacter 1996 1 3 138 144 (Pubitemid 126671139)
14. De Francesco V., Margiotta M., Zullo A., Hassan C., Giorgio F., Burattini O., Stoppino G., Cea U., Pace A., Zotti M., Morini S., Panella C., Ierardi E., Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy Journal of Antimicrobial Chemotherapy 2007 59 4 783 785 (Pubitemid 47073419)
15. Gisbert J. P., Pajares R., Pajares J. M., Evolution of Helicobacter pylori therapy from a meta-analytical perspective Helicobacter 2007 12 supplement 2 50 58 (Pubitemid 350076232)
16. De Francesco V., Giorgio F., Hassan C., Manes G., Vannella L., Panella C., Ierardi E., Zullo A., Worldwide H. pylori antibiotic resistance: a systematic review Journal of Gastrointestinal and Liver Diseases 2010 19 4 409 414
17. Fischbach L. A., Goodman K. J., Feldman M., Aragaki C., Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis International Journal of Epidemiology 2002 31 1 128 139 (Pubitemid 34284915)
18. Janssen M. J., Van Oijen A. H., Verbeek A. L., Jansen J. B., De Boer W. A., A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole Alimentary Pharmacology Therapeutics 2001 15 5 613 624 (Pubitemid 32385865)
19. Laheij R. J., Rossum L. G., Jansen J. B., Straatman H., Verbeek A. L., Evaluation of treatment regimens to cure Helicobacter pylori infectiona meta-analysis Alimentary Pharmacology Therapeutics 1999 13 7 857 864 (Pubitemid 29312769)
20. Malfertheiner P., Mégraud F., O'Morain C., Hungin A. P. S., Jones R., Axon A., Graham D. Y., Tytgat G., Current concepts in the management of Helicobacter pylori infectionthe Maastricht 2-2000 Consensus Report Alimentary Pharmacology Therapeutics 2002 16 2 167 180 (Pubitemid 34146357)
21. Katelaris P. H., Forbes G. M., Talley N. J., Crotty B., A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study Gastroenterology 2002 123 6 1763 1769 (Pubitemid 35408299)
22. Calvet X., Ducons J., Guardiola J., Tito L., Andreu V., Bory F., Guirao R., One-week triple vs. quadruple therapy for Helicobacter pylori infectiona randomized trial Alimentary Pharmacology Therapeutics 2002 16 7 1261 1267
23. Luther J., Higgins P. D., Schoenfeld P. S., Moayyedi P., Vakil N., Chey W. D., Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability American Journal of Gastroenterology 2010 105 1 65 73
24. Graham D. Y., Dore M. P., Helicobacter pylori therapy demystified Helicobacter 2011 16 5 343 345
25. Chey W. D., Wong B. C., American College of Gastroenterology guideline on the management of Helicobacter pylori infection American Journal of Gastroenterology 2007 102 8 1808 1825 (Pubitemid 47206706)
26. Caselli M., Zullo A., Maconi G., Parente F., Alvisi V., Casetti T., Sorrentino D., Gasbarrini G., Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy Digestive and Liver Disease 2007 39 8 782 789 (Pubitemid 47046643)
27. Maconi G., Tosetti C., Miroglio G., Parente F., Colombo E., Sainaghi M., Bianchi Porro G., Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy Alimentary Pharmacology Therapeutics 1999 13 11 1499 1504 (Pubitemid 29516263)
28. Georgopoulos S. D., Ladas S. D., Karatapanis S., Triantafyllou K., Spiliadi C., Mentis A., Artikis V., Raptis S. A., Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies Alimentary Pharmacology Therapeutics 2002 16 3 569 575 (Pubitemid 34214538)
29. Mantzaris G. J., Petraki K., Archavlis E., Amberiadis P., Christoforidis P., Kourtessas D., Chiotakakou E., Triantafyllou G., Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: 24-month follow-up study European Journal of Gastroenterology and Hepatology 2002 14 11 1237 1243 (Pubitemid 35471532)
30. Karatapanis S., Georgopoulos S. D., Papastergiou V., 7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial Acta Gastroenterol Belg 2011 74 3 407 412
31. Rokkas T., Sechopoulos P., Robotis I., Margantinis G., Pistiolas D., Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen American Journal of Gastroenterology 2009 104 1 21 25
32. Boyanova L., Mentis A., Gubina M., Rozynek E., Gosciniak G., Kalenic S., Gral V., Kupcinskas L., Kantareken B., Aydin A., Archimandritis A., Dzierzanowska D., Vcev A., Ivanova K., Marina M., Mitov I., Petrov P., zden A., Popova M., The status of antimicrobial resistance of Helicobacter pylori in Eastern Europe Clinical Microbiology and Infection 2002 8 7 388 396 (Pubitemid 34993815)
33. Glupczynski Y., Mégraud F., Lopez-Brea M., Andersen L. P., European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori European Journal of Clinical Microbiology and Infectious Diseases 2001 20 11 820 823 (Pubitemid 34020461)
34. Mentis A. F., Roma E., Pangalis A., Katsiyiannakis E., Susceptibilities of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics Journal of Antimicrobial Chemotherapy 1999 44 5 720 722 (Pubitemid 29532857)
35. Gisbert J. P., Gisbert J. L., Marcos S., Jimenez-Alonso I., Moreno-Otero R., Pajares J. M., Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients Alimentary Pharmacology Therapeutics 2008 27 4 346 354
36. Seppl K., Kosunen T. U., Veijola L., Sipponen P., Arkkila P. E. T., Rautelin H., Tilvis R., Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects Scandinavian Journal of Gastroenterology 2008 43 9 1149 1150
37. Fuccio L., Zagari R. M., Bazzoli F., What is the best salvage therapy for patients with Helicobacter pylori infection? Nature Clinical Practice Gastroenterology and Hepatology 2008 5 11 608 609
38. Huang J. Q., Hunt R. H., Treatment after failure: the problem of non-responders Gut 1999 45 supplement 1 I40 I44
39. Chuah S. K., Tsay F. W., Hsu P. I., Wu D. C., A new look at anti-Helicobacter pylori therapy World Journal of Gastroenterology 2011 17 35 3971 3975
40. Graham D. Y., Lu H., Yamaoka Y., A report card to grade Helicobacter pylori therapy Helicobacter 2007 12 4 275 278 (Pubitemid 47196342)
41. Graham D. Y., Efficient identification and evaluation of effective Helicobacter pylori therapies Clinical Gastroenterology and Hepatology 2009 7 2 145 148
42. Graham D. Y., Fischbach L., Helicobacter pylori treatment in the era of increasing antibiotic resistance Gut 2010 59 8 1143 1153
43. Gisbert J. P., Calvet X., O'Connor A., Mégraud F., O'Morain C. A., Sequential therapy for Helicobacter pylori eradication: a critical review Journal of Clinical Gastroenterology 2010 44 5 313 325
44. Moayyedi P., Sequential regimens for Helicobacter pylori eradication The Lancet 2007 370 9592 1010 1012 (Pubitemid 47419006)
45. Jafri N. S., Hornung C. A., Howden C. W., Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment Annals of Internal Medicine 2008 148 12 923 931 (Pubitemid 351860824)
46. Tong J. L., Ran Z. H., Shen J., Xiao S. D., Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis Journal of Clinical Pharmacy and Therapeutics 2009 34 1 41 53
47. Gatta L., Vakil N., Leandro G., Di Mario F., Vaira D., Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children American Journal of Gastroenterology 2009 104 12 3069 3079
48. Zullo A., De Francesco V., Hassan C., Morini S., Vaira D., The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis Gut 2007 56 10 1353 1357 (Pubitemid 47517826)
49. Vaira D., Zullo A., Vakil N., Gatta L., Ricci C., Perna F., Hassan C., Bernabucci V., Tampieri A., Morini S., Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial Annals of Internal Medicine 2007 146 8 556 563 (Pubitemid 351650536)
50. Wu D. C., Hsu P. I., Wu J. Y., Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection Clinical Gastroenterology and Hepatology 2010 8 1 36.e1 41.e1
51. Paulsen I. T., Brown M. H., Skurray R. A., Proton-dependent multidrug efflux systems Microbiological Reviews 1996 60 4 575 608 (Pubitemid 26415669)
52. Webber M. A., Piddock L. J., The importance of efflux pumps in bacterial antibiotic resistance Journal of Antimicrobial Chemotherapy 2003 51 1 9 11 (Pubitemid 36163821)
53. Roberts M. C., Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics Molecular Biotechnology 2004 28 1 47 62 (Pubitemid 41490583)
54. Molina-Infante J., Pazos-Pacheco C., Perez-Gallardo B., Efficacy of nonbismuth quadruple concomitant therapy for H. pylori infection in a setting with high clarithromycin resistance Helicobacter 2011 138, article 880 supplement 1
55. Molina-Infante J., Perez-Gallardo B., Fernandez-Bermejo M., Hernandez-Alonso M., Vinagre G., Dueas C., Mateos-Rodriguez J. M., Gonzalez-Garcia G., Abadia E. G., Gisbert J. P., Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication Alimentary Pharmacology Therapeutics 2010 31 10 1077 1084
56. de Boer W. A., Kuipers E. J., Kusters J. G., Sequential therapy; a new treatment for Helicobacter pylori infection: but is it ready for general use? Digestive and Liver Disease 2004 36 5 311 314 (Pubitemid 41115459)
57. Snchez-Delgado J., Calvet X., Bujanda L., Gisbert J. P., Tit L., Castro M., Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice American Journal of Gastroenterology 2008 103 9 2220 2223
58. O'Morain C. A., O'Connor J. P., Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection? Nature Clinical Practice Gastroenterology and Hepatology 2009 6 1 8 9
59. Moayyedi P., Malfertheiner P., Editorial: sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? American Journal of Gastroenterology 2009 104 12 3081 3083
60. Luther J., Chey W. D., Sequential therapy for Helicobacter pylori: a two for one deal that's worth the extra effort? Gastroenterology 2009 136 2 720 722
61. Choi W. H., Park D. I., Oh S. J., Baek Y. H., Hong C. H., Hong E. J., Song M. J., Park S. K., Park J. H., Kim H. J., Cho Y. K., Sohn C. I., Jeon W. K., Kim B. I., Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea The Korean Journal of Gastroenterology 2008 51 5 280 284
62. Gao X. Z., Qiao X. L., Song W. C., Wang X. F., Liu F., Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication World Journal of Gastroenterology 2010 16 34 4357 4362
63. Greenberg E. R., Anderson G. L., Morgan D. R., Torres J., Chey W. D., Bravo L. E., Dominguez R. L., Ferreccio C., Herrero R., Lazcano-Ponce E. C., Meza-Montenegro M. M., Pea R., Pea E. M., Salazar-Martnez E., Correa P., Martnez M. E., Valdivieso M., Goodman G. E., Crowley J. J., Baker L. H., 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial The Lancet 2011 378 9790 507 514
64. Graham D. Y., Rimbara E., Understanding and appreciating sequential therapy for Helicobacter pylori eradication Journal of Clinical Gastroenterology 2011 45 4 309 313
65. Park H. G., Jung M. K., Jung J. T., Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients Alimentary Pharmacology Therapeutics 2012 35 1 56 65
66. Merali A., Leontiadis G. I., Sequential therapymore studies are still required Alimentary Pharmacology Therapeutics 2012 35 1 194 195
67. Gisbert J. P., Calvet X., Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori Alimentary Pharmacology Therapeutics 2011 34 6 604 617
68. Fakheri H., Taghvaei T., Hosseini V., Bari Z., A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial Helicobacter 2012 17 1 43 48
69. Graham D. Y., Shiotani A., New concepts of resistance in the treatment of Helicobacter pylori infections Nature Clinical Practice Gastroenterology and Hepatology 2008 5 6 321 331 (Pubitemid 351803603)
70. Treiber G., Wittig J., Ammon S., Walker S., van Doorn L. J., Klotz U., Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study) Archives of Internal Medicine 2002 162 2 153 160 (Pubitemid 34098184)
71. Essa A. S., Kramer J. R., Graham D. Y., Treiber G., Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing concomitant therapy versus triple therapy for Helicobacter pylori eradication Helicobacter 2009 14 2 109 118
72. Fischbach L. A., Bravo L. E., Zarama G. R., Bravo J. C., Ojha P. R., Priest E. L., Collazos T., Casabon L. A., Guerrero L. Z., Singh P. K., Correa P., A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country Helicobacter 2009 14 2 100 108
73. Hsu P. I., Wu D. C., Wu J. Y., Graham D. Y., Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicilin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days Helicobacter 2011 16 2 146 152
74. Georgopoulos S., Papastergiou V., Xirouchakis E., Evaluation of a four-drug, three-antibiotic, nonbismuth-containing concomitant therapy as first-line Helicobacter pylori eradication regimen in Greece Helicobacter 2011 16 2 139 145
75. Georgopoulos S. D., Xirouchakis E., Laoudi F., Clinical evaluation of a 10-day regimenwith esomeprazole, metronidazole, amoxycilline and clarithromycin for the eradication of Helicobacter pylori (E-MACH study) Helicobacter 2011 16, article A136 supplement 1
76. Liou J. M., Lin J. T., Chang C. Y., Chen M. J., Cheng T. Y., Lee Y. C., Chen C. C., Sheng W. H., Wang H. P., Wu M. S., Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design Gut 2010 59 5 572 578
77. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E. J., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 2007 56 6 772 781 (Pubitemid 46854190)
78. Fischbach L. A., van Zanten S., Dickason J., Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies Alimentary Pharmacology Therapeutics 2004 20 10 1071 1082 (Pubitemid 39657940)
79. Fischbach L., Evans E. L., Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori Alimentary Pharmacology Therapeutics 2007 26 3 343 357 (Pubitemid 47063149)
80. Michopoulos S., Tsibouris P., Bouzakis H., Balta A., Vougadiotis J., Broutet N., Kralios N., Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-Iine Helicobacter pylori eradication regimens Alimentary Pharmacology Therapeutics 2000 14 6 737 744 (Pubitemid 30352740)
81. Perri F., Festa V., Merla A., Quitadamo M., Clemente R., Andriulli A., Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection Helicobacter 2002 7 2 99 104 (Pubitemid 34507075)
82. Garcia N., Calvet X., Gene E., Campo R., Brullet E., Limited usefulness of a seven-day twice-a-day quadruple therapy European Journal of Gastroenterology and Hepatology 2000 12 12 1315 1318 (Pubitemid 32057372)
83. de Boer W. A., van Etten R. J., Schneeberger P. M., Tytgat G. N., A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule American Journal of Gastroenterology 2000 95 3 641 645 (Pubitemid 30123896)
84. de Boer W. A., A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule Expert Opinion on Investigational Drugs 2001 10 8 1559 1566
85. Laine L., Hunt R., EI-Zimaity H., Nguyen B., Osato M., Spénard J., Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial American Journal of Gastroenterology 2003 98 3 562 567 (Pubitemid 36348526)
86. O'Morain C., Borody T., Farley A., De Boer W. A., Dallaire C., Schuman R., Piotrowski J., Fallone C. A., Tytgat G., Mégraud F., Spénard J., Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study Alimentary Pharmacology Therapeutics 2003 17 3 415 420 (Pubitemid 36259404)
87. Saleem A., Qasim A., O'Connor H. J., O'Morain C. A., Pylera for the eradication of Helicobacter pylori infection Expert Review of Anti-Infective Therapy 2009 7 7 793 799
88. Malfertheiner P., Bazzoli F., Delchier J. C., Celiski K., Gigure M., Rivire M., Mégraud F., Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial The Lancet 2011 377 9769 905 913
89. Romano M., Cuomo A., Gravina A. G., Miranda A., Iovene M. R., Tiso A., Sica M., Rocco A., Salerno R., Marmo R., Federico A., Nardone G., Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial Gut 2010 59 11 1465 1470
90. Berning M., Krasz S., Miehlke S., Should quinolones come first in Helicobacter pylori therapy? Therapeutic Advances in Gastroenterology 2011 4 2 103 114
91. Perna F., Zullo A., Ricci C., Hassan C., Morini S., Vaira D., Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance Digestive and Liver Disease 2007 39 11 1001 1005 (Pubitemid 350018698)
92. Bogaerts P., Berhin C., Nizet H., Glupczynski Y., Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium Helicobacter 2006 11 5 441 445 (Pubitemid 44352615)
93. Carothers J. J., Bruce M. G., Hennessy T. W., Bensler M., Morris J. M., Reasonover A. L., Hurlburt D. A., Parkinson A. J., Coleman J. M., McMahon B. J., The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection Clinical Infectious Diseases 2007 44 2 e5 e8
94. van der Linden P. D., Sturkenboom M. C., Herings R. M., Leufkens H. G., Stricker B. H., Fluoroquinolones and risk of achilles tendon disorders: case-control study British Medical Journal 2002 324 7349 1306 1307 (Pubitemid 34606771)
95. Croom K. F., Goa K. L., Levofloxacin: a review of its use in the treatment of bacterial infections in the United States Drugs 2003 63 24 2769 2802 (Pubitemid 38049994)
96. Bilardi C., Dulbecco P., Zentilin P., Reglioni S., Iiritano E., Parodi A., Accornero L., Savarino E., Mansi C., Mamone M., Vigneri S., Savarino V., A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial Clinical Gastroenterology and Hepatology 2004 2 11 997 1002 (Pubitemid 39539749)
97. Saad R. J., Schoenfeld P., Kim H. M., Chey W. D., Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis American Journal of Gastroenterology 2006 101 3 488 496 (Pubitemid 46894012)
98. Gisbert J. P., Bermejo F., Castro-Fernndez M., Pérez-Aisa A., Fernndez-Bermejo M., Tomas A., Barrio J., Bory F., Almela P., Snchez-Pobre P., Cosme A., Ortiz V., Nio P., Khorrami S., Benito L. M., Carneros J. A., Lamas E., Modolell I., Franco A., Ortuo J., Rodrigo L., Garca-Durn F., O'Callaghan E., Ponce J., Valer M. P., Calvet X., Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients American Journal of Gastroenterology 2008 103 1 71 76
99. Gisbert J. P., Second-line rescue therapy of Helicobacter pylori infection Therapeutic Advances in Gastroenterology 2009 2 6 331 356
100. Gisbert J. P., Gisbert J. L., Marcos S., Moreno-Otero R., Pajares J. M., Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures Alimentary Pharmacology Therapeutics 2006 24 10 1469 1474 (Pubitemid 44657124)
101. Nishizawa T., Suzuki H., Hibi T., Quinolone-based third-line therapy for Helicobacter pylori eradication Journal of Clinical Biochemistry and Nutrition 2009 44 2 119 124
102. Karatapanis S., Skorda L., Georgopoulos S. D., Papantoniou N., Papastergiou V., Ntoutsikos K., Komnianides, Lisgos P., Levofloxacin-based triple therapy versus bismuth-based quadruple therapy as a second line treatment for the eradication of H. pylori infection Annals of Gastroenterology 2009 22 4 263 267
103. Krystallis C., Kamberoglou D., Pistiolas D., Anifanti C., Koutsoumbas A., Doulgeroglou V., Tzias V., A new second-line sequential regimen for Helicobacter pylori eradication based on levofloxacin: a pilot study Digestive Diseases and Sciences 2010 55 12 3630 3631
104. Pontone S., Standoli M., Angelini R., Pontone P., Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice Digestive and Liver Disease 2010 42 8 541 543
105. Graham D. Y., Osato M. S., Hoffman J., Opekun A. R., Anderson S. Y., Kwon D. H., El-Zimaity H. M. T., Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study Alimentary Pharmacology Therapeutics 2000 14 6 745 750 (Pubitemid 30352741)
106. Lee B. H., Kim N., Hwang T. J., Lee S. H., Park Y. S., Hwang J. H., Kim J. W., Jeong S. H., Lee D. H., Jung H. C., Song I. S., Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea Helicobacter 2010 15 1 38 45
107. Sun Q., Liang X., Zheng Q., Liu W., Xiao S., Gu W., Lu H., High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication Helicobacter 2010 15 3 233 238
108. Graham D. Y., Javed S. U., Keihanian S., Abudayyeh S., Opekun A. R., Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States Journal of Gastroenterology 2010 45 8 816 820
109. Rimbara E., Fischbach L. A., Graham D. Y., Optimal therapy for Helicobacter pylori infections Nature Reviews Gastroenterology and Hepatology 2011 8 2 79 88
110. Gisbert J. P., Calvet X., Review article: rifabutin in the treatment of refractory Helicobacter pylori infection Alimentary Pharmacology Therapeutics 2012 35 2 209 221
111. Treiber G., Ammon S., Malfertheiner P., Klotz U., Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures Helicobacter 2002 7 4 225 231
112. Malfertheiner P., Megraud F., O'Morain C. A., Management of Helicobacter pylori infectionthe Maastricht IV/ Florence Consensus Report Gut 2012 61 5 646 664